Significance of 3q27-3q29-related p63 protein expression in diffuse large B-cell lymphoma

( views:, downloads: )
CHEN Zhen-wen(Department of Pathology, Fenyang College of Shanxi Medical University, Fenyang 032200, China)
WANG Jin-fen()
WANG Guo-ping()
ZHANG Hong-wei()
LIU Dong-mei(Department of Pathology, Fenyang College of Shanxi Medical University, Fenyang 032200, China)
XU Yi-rong(Department of Pathology, Fenyang College of Shanxi Medical University, Fenyang 032200, China)
ZHANG Zhao-xia(Department of Pathology, Fenyang College of Shanxi Medical University, Fenyang 032200, China)
TIAN Lin()
Journal Title:
Volume 19, Issue 03, 2010
Key Word:

Abstract: Objective To investigate the expressions and clinicopathological significance of 3q27-3q29-related p63 protein in diffuse large B-cell lymphoma (DLBCL). Methods An immunohistochemical Envision~(TM) method was used to detect the expressions of p53 and 3q27-3q29-related p63 protein in 102 cases of DLBCL and 15 cases of reactive hyperplasia of lymph node (RHL). Results The tumor cell expressions of p53(62 %) and p63(56 %) in DLBCL were significantly higher than that in RHL (0 and 13 % P < 0.05). The expressions of p53 and p63 were significantly different (1) between stage Ⅰ + Ⅱ (the positive rate 48.3 % and 41.4 %, respectively) and stage Ⅲ+Ⅳ(the positive rate 79.5 % and 75 %, respectively; P <0.05), (2) between GCB type (the positive rate 28 % and 28 %, respectively) and non-GCB type(the positive rate 72.7 % and 64.9 %, respectively; P <0.05). The expressions of p53 and p63 had no relationship to gender, age, B symptoms and locations. The expression of p53 was positively correlated with that of p63 in DLBCL (P <0.05, Cp=0.629). p53 and p63 protein expression in negative group the 5-year overall survival rate is higher than that in positive group (38 % and 6 %, 51% and 4 %, respectively), the difference was statistically significant (P <0.05). Conclusion It was likely that p63, as the oncogene, participated in the occurrence and development of DLBCL together with p53. Also, p63 and p53 might play a synergistic role in the occurrence DLBCL. Combined detection of 3q27-3q29-related 1963 protein and p53 protein in DLBCL, might be one of the indicators to the prognosis of DLBCL.

  • [1]Gatter KC,Wamke RA.Diffuse large B-cell lymphoma//Jaffe ES,Harris NL,Stein H,et al.Pathology and Genetics of Tumours of Haematopoetic and Lymphoid Tissues.Lyon:IARC Press,2001:171-174.
  • [2]Berglund M,Enblad G,Flordal E,et al.Chromosomal imbalances in diffuse large B-cell lymphoma detected by comparative genomic hybridization.Mod Pathol,2002,15:807-816.
  • [3]Leroy K,Haioun C,Lepage E,et al.p53 gene mutations are associated with poor survival in low and lowintermediate risk diffuse large B-cell lymphomas.Ann Oncol,2002,13:1108-1115.
  • [4]Armitage JO.Staging non-Hodgkin lymphoma.CA Cancer J Clin,2005,55:368-376.
  • [5]刘冬梅,王晋芬,张建中.应用组织芯片技术研究bcl-10、Topolla及Ki-67在MALT型淋巴瘤中的表达和意义.白血病·淋巴瘤,2005,14:92-94.
  • [6]Jinfen W,Lillian Y,William W,et al.Distribution and ZAP-70 expression of WHO lymphoma categories in Shanxi,China:A review of 447 cases using a tissue microarray technique.Appl Immunohistochem Mol Morphol,2005,13:323-332.
  • [7]Hans CP,Weisenburger DD,Greiner TC,et al.Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray.Blood,2004,103:275-282.
  • [8]Levine AJ,Perry ME,Chang A,et al.The 1993 Walter Hubert Lecture:the role of p53 tumour-suppressor gene in tumorigenesis.Br J Cancer,1994,69:409.-416.
  • [9]Joypaul BV,Newman EL.Expression of p53 protein in normal,dyplastic and malignant gastric mucosa:an immunohistochemical study.J Pathol,1993,170:279-284.
  • [10]Petitjean A,Achatz MI,Borresen-Dale AL,et al.TP53 mutations in human cancers:functional selection and impact on cancer prognosis and outcomes.Oncogene,2007,26:2157-2165.
  • [11]Vogelstein B,Lane D,Levine AJ.Surfing the p53 network.Nature,2000,408:307-310.
  • [12]沈艳,林汉良,谢丹,等.非霍奇金淋巴瘤中McM7、p53和Ki-67的表达.临床与实验病理学杂志,2005,21:567-569.
  • [13]Colomo L,Lopez-Guillermo A,Perales M,et al.Clinical impact of the differentiation profile assessed by inununophenotyping in patients with diffuse large B-cell lymphoma.Blood,2003,101:78-84.
  • [14]Jang KY,Hwang SH,Kwon KS,et al.SIRT1 expression is associated with poor prognosis of diffuse,large B-cell lymphoma.Am J Surg Pathol.2008,32:1523-1531.
  • [15]Young KH,Leroy K,Moiler MB,et al.Structural profiles of TP53 gene mutations predict clinical outcome in diffuse large B-cell lymphoma:an international collaborative study.Blood,2008,112:3088-3098.
  • [16]Mills AA,Zheng B,Wang XJ,et al.p63 is a p53 homologue required for limb and epidermal morphogenosis.Nature,1999,398:708-713.
  • [17]Senoo M,Pinto F,Crum CP,et al.p63 is essential for the proliferative potential of stem cells in stratified epithelia.Cell,2007,129:523-536.
  • [18]Hu H,Xiao SH,Li AD,et al.Elevated expression of p63 protein in human esophagus squamous cell carcinomas.Int J Cancer,2002,102:580-583.
  • [19]Zigeuner R,Tsybrovskyy O,Ratschek M,et al.Prognostic impact of p63 and p53 expression in upper urinary tract transitional carcinoma.Urology,2004,63:1079-1083.
  • [20]Dickson BC,Li SQ,Wunder JS,et al.Giant cell tumor of bone express p63.Modern Pathol,2008,21:369-375.
  • [21]Park CK,Oh YH.Expression of p63 in reactive hyperplasias and malignant lymphomas.J Korean Med Sci,2005,20:752-758.
  • [22]Hallack Neto AE,Siqueira SA,Dulley FL,et al.p63 protein expression in high risk diffuse large B-cell lymphoma.J Clin Pathol,2009,62:77-79.
  • [23]陈振文,王晋芬,王全红,等.p63在间变性大细胞淋巴瘤中的表达及意义.白血病·淋巴瘤,2004,13:159-161.
  • [24]左学兰,周颖,周新,等.存活蛋白和p63蛋白在B细胞非霍奇金淋巴瘤组织中的表达及其对细胞凋亡和增殖的作用.中国实验血液学杂志,2007,15:99-102.
  • [25]Wang TY,Chen BF,Yang YC,et al.Histologic and immunophenotypic classification of cervical carcinomas by expression of the p53 homologue p63:a study of 250 cases.Hum Pathol,2001,32:479-486.
  • [26]Hedvat CV,Teruya-Feldstein J,Puig P,et al.Expression of p63 in diffuse large B-cell lymphoma.Appl Immunohistochem Mol Morphol,2005,13:237-242.
  • [27]Flores ER.The roles of p63 in cancer.Cell Cycle,2007,6:300-304.
WanfangData CO.,Ltd All Rights Reserved
About WanfangData | Contact US
Healthcare Department, Fuxing Road NO.15, Haidian District Beijing, 100038 P.R.China
Tel:+86-010-58882616 Fax:+86-010-58882615